rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Judith M. Matthews

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Eton Pharmaceuticals; Chief Financial Officer, Iterum Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
24
Buys
1
Sells
4
Bought
$52K
Sold
$188K
Companies
2
Companies where not an officer
0
First trade
24 May 2018
Last trade
31 Jul 2026
Last filed
4 Aug 2026

Companies traded

Where they are an officer
ETON Eton PharmaceuticalsOfficer · Pharmaceuticals · last 31 Jul 20260 buys · 0 sells
Iterum TherapeuticsOfficer · last 31 Mar 20231 buy · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
31 Jul 2026filed 4 Aug 2026ETON Eton Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—32,246 at $0.00filing
31 Jul 2026filed 4 Aug 2026ETON Eton Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—32,246 at $0.00filing
31 Mar 2023filed 3 Apr 2023Iterum Therapeuticsoption or derivativeSEC FORM 4 Code A—100,000 at $0.00filing
11 Mar 2023filed 14 Mar 2023Iterum Therapeuticsoption or derivativeSEC FORM 4 Code M—6,666 at $0.00filing
11 Mar 2023filed 14 Mar 2023Iterum TherapeuticsSEC FORM 4 Code A—6,666 at $0.00filing
11 Mar 2023filed 14 Mar 2023Iterum TherapeuticsSEC FORM 4 Code F$2,7682,883 at $0.96filing
14 Mar 2022filed 15 Mar 2022Iterum TherapeuticsSEC FORM 4 Sold$18K47,132 at $0.38filing
14 Mar 2022filed 15 Mar 2022Iterum TherapeuticsSEC FORM 4 Sold$20K63,340 at $0.31filing
11 Mar 2022filed 15 Mar 2022Iterum Therapeuticsoption or derivativeSEC FORM 4 Code M—100,000 at $0.00filing
11 Mar 2022filed 15 Mar 2022Iterum TherapeuticsSEC FORM 4 Code A—100,000 at $0.00filing
23 Jun 2021filed 25 Jun 2021Iterum Therapeuticsoption or derivativeSEC FORM 4 Code A—1,936,000 at $0.00filing
11 Mar 2021filed 15 Mar 2021Iterum Therapeuticsoption or derivativeSEC FORM 4 Code A—200,000 at $0.00filing
26 Jan 2021filed 27 Jan 2021Iterum TherapeuticsSEC FORM 4 Sold$59K33,868 at $1.73filing
25 Jan 2021filed 27 Jan 2021Iterum TherapeuticsSEC FORM 4 Code A—62,500 at $0.00filing
30 Sep 2020filed 2 Oct 2020Iterum TherapeuticsSEC FORM 4 Sold$92K56,130 at $1.64filing
15 Feb 2019filed 19 Feb 2019Iterum Therapeuticsoption or derivativeSEC FORM 4 Code A—30,000 at $0.00filing
30 May 2018filed 30 May 2018Iterum TherapeuticsSEC FORM 4 Code C—10,980filing
30 May 2018filed 30 May 2018Iterum TherapeuticsSEC FORM 4 Code C—3,038filing
30 May 2018filed 30 May 2018Iterum TherapeuticsSEC FORM 4 Code C—2,466filing
30 May 2018filed 30 May 2018Iterum TherapeuticsSEC FORM 4 Bought$52K4,000 at $13.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed5

Buys in green, sells in red, by the company’s sector.

Related people

David KrempaChief Business Officer · Chief Business Officer at Eton Pharmaceuticals, filing Form 4 there in the last year
Paul Maier VDirector · Director at Eton Pharmaceuticals, filing Form 4 there in the last year
Sean BrynjelsenPresident & CEO · President & CEO at Eton Pharmaceuticals, filing Form 4 there in the last year
Ipek Erdogan-TrinkausChief Commercial Officer · Chief Commercial Officer at Eton Pharmaceuticals, filing Form 4 there in the last year
Norbert G. RiedelDirector · Director at Eton Pharmaceuticals, filing Form 4 there in the last year